Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study.
Kochman W, Dobrzycki S, Nowak KS, Chlopicki S, Kralisz P, Prokopczuk P, Bachorzewska-Gajewska H, Gugala K, Niewada M, Mezynski G, Poniatowski B, Korecki J, Musial WJ. Kochman W, et al. J Thromb Thrombolysis. 2004 Apr;17(2):127-31. doi: 10.1023/B:THRO.0000037668.89547.a6. J Thromb Thrombolysis. 2004. PMID: 15306748
Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ. Dobrzycki S, et al. Among authors: kochman w. Kardiol Pol. 2006 Aug;64(8):793-9; discussion 800-1. Kardiol Pol. 2006. PMID: 16981054 Clinical Trial.
Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Kochman W, Korecki J, Poniatowski B, Zuk J, Sitniewska E, Bachorzewska-Gajewska H, Sienkiewicz J, Musial WJ. Dobrzycki S, et al. Among authors: kochman w. Eur Heart J. 2007 Oct;28(20):2438-48. doi: 10.1093/eurheartj/ehm369. Epub 2007 Sep 20. Eur Heart J. 2007. PMID: 17884846 Clinical Trial.
[Outcome of invasive treatment in patients with acute coronary syndrome during a 24-hour period at the Invasive Cardiology Clinical Hospital at the Medical Academy of Białymstok].
Kochman W, Kralisz P, Dobrzycki S, Nowak K, Prokopczuk P, Zuk J, Gajewska-Bachórzewska H, Poniatowski B, Korecki J, Musiał W, Gugała K, Siwołowski P, Mezyński G. Kochman W, et al. Kardiol Pol. 2003 Jun;58 Suppl 4:IV57-60. Kardiol Pol. 2003. PMID: 20527121 Polish. No abstract available.
44 results